GMS Infectious Diseases
Volume 2 (2014)
- Research Article
Look at your patient: appropriate antimicrobial therapy in patients with community- versus hospital-acquired bacteremic sepsis
Scheithauer S, Haefner H, Schwanz T, Haase G, Lemmen SGMS Infect Dis. 2014;2:Doc07 (2014-09-17) - Expert's Opinion
Brauchen wir die Grippemittel Tamiflu und Relenza?
Schmidtke M, Mertens T, Gesellschaft für Virologie e.V. (GfV), Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e.V. (DVV), Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG)GMS Infect Dis. 2014;2:Doc06 (2014-08-25) - Research Article
Results on the mandatory notification of carbapenem-resistant Gram-negative bacteria, Hesse, Germany, January 2012 – April 2013
Hauri AM, Kaase M, Hunfeld KP, Heinmüller P, Imirzalioglu C, Wichelhaus TA, Fitzenberger J, Wirtz AGMS Infect Dis. 2014;2:Doc04 (2014-04-16) - Guideline
[S1 guideline diagnosis and therapy of cutaneous larva migrans (creeping disease)]
Sunderkötter C, von Stebut E, Schöfer H, Mempel M, Reinel D, Wolf G, Meyer V, Nast A, Burchard GDGMS Infect Dis. 2014;2:Doc03 (2014-04-16) - Leitlinie
[Gonorrhoea in adults and in adolescents]
Bremer V, Brockmeyer NH, Buder S, Eigentler A, Esser S, Hagedorn HJ, Hartmann M, Hörauf A, Kern W, Kohl PK, Köhler E, Köhn FM, Kresken M, Mayr C, Meyer T, Möst J, Mylonas I, Nitschke H, Petry KU, Plettenberg A, Potthoff A, Rieg S, Spornraft-Ragaller P, Rasokat H, Schöfer H, Schneede P, Throm W, Walter G, Weidner W, Wichelhaus TAGMS Infect Dis. 2014;2:Doc02 (2014-04-08) - Review Article
Intracellular habitat of pathogenic microorganisms: implications for antimicrobial chemotherapy
Hof HGMS Infect Dis. 2014;2:Doc01 (2014-02-07)
